-
2
-
-
0000083831
-
The probable involvement of the factors other than intraocular pressure in the pathogenesis of glaucoma
-
In: Drance SM Van Buskirk EM Neufeld AH Eds Baltimore Lippincott Williams and Wilkins
-
Flammer J, Gasser P, Prunte C. The probable involvement of the factors other than intraocular pressure in the pathogenesis of glaucoma. In: Drance SM, Van Buskirk EM, Neufeld AH, eds. Pharmacology of Glaucoma. Baltimore: Lippincott Williams and Wilkins; 1992: 273-283
-
(1992)
Pharmacology Of Glaucoma
, pp. 273-283
-
-
Flammer, J.1
Gasser, P.2
Prunte, C.3
-
3
-
-
0032189334
-
The effectiveness of intraocular pressure reduction in the treatment of normal-Tension glaucoma
-
Collaborative Normal-Tension Glaucoma Study Group
-
The effectiveness of intraocular pressure reduction in the treatment of normal-Tension glaucoma. Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol. 1998;126: 498-505
-
(1998)
Am J Ophthalmol
, vol.126
, pp. 498-505
-
-
-
4
-
-
0032189255
-
Comparison of glaucomatous progression between untreated patients with normal-Tension glaucoma and patients with therapeutically reduced intraocular pressures
-
Collaborative Normal-Tension Glaucoma Study Group
-
Comparison of glaucomatous progression between untreated patients with normal-Tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol. 1998;126: 487-497
-
(1998)
Am J Ophthalmol
, vol.126
, pp. 487-497
-
-
-
5
-
-
0036822851
-
Reduction of intraocular pressure and glaucoma progression: Results from the Early Manifest Glaucoma Trial
-
Heijl A, Leske MC, Bengtsson B, et al. Reduction of intraocular pressure and glaucoma progression: Results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002; 120: 1268-1279
-
(2002)
Arch Ophthalmol
, vol.120
, pp. 1268-1279
-
-
Heijl, A.1
Leske, M.C.2
Bengtsson, B.3
-
8
-
-
0025934494
-
Systemic hypotension: A risk factor for glaucomatous damage?
-
Kaiser HJ, Flammer J. Systemic hypotension: A risk factor for glaucomatous damage? Ophthalmologica. 1991;203: 105-108
-
(1991)
Ophthalmologica
, vol.203
, pp. 105-108
-
-
Kaiser, H.J.1
Flammer, J.2
-
9
-
-
82455219161
-
Normal tension glaucoma in patients with obstructive sleep apnea/hypopnea syndrome
-
Lin PW, Friedman M, Lin HC, et al. Normal tension glaucoma in patients with obstructive sleep apnea/hypopnea syndrome. J Glaucoma. 2011;20: 553-558
-
(2011)
J Glaucoma
, Issue.20
, pp. 553-558
-
-
Lin, P.W.1
Friedman, M.2
Lin, H.C.3
-
10
-
-
33846334841
-
Prevalence of normal tension glaucoma in obstructive sleep apnea syndrome patients
-
Sergi M, Salerno DE, Rizzi M, et al. Prevalence of normal tension glaucoma in obstructive sleep apnea syndrome patients. J Glaucoma. 2007;16: 42-46
-
(2007)
J Glaucoma
, vol.16
, pp. 42-46
-
-
Sergi, M.1
Salerno, D.E.2
Rizzi, M.3
-
11
-
-
0021363437
-
Do patients with low tension glaucoma have particular cardiovascular characteristics?
-
Demailly P, Cambien F, Plouin PF, et al. Do patients with low tension glaucoma have particular cardiovascular characteristics? Ophthalmologica. 1984;188: 65-75
-
(1984)
Ophthalmologica
, vol.188
, pp. 65-75
-
-
Demailly, P.1
Cambien, F.2
Plouin, P.F.3
-
12
-
-
0015888639
-
Studies of factors involved in the production of low tension glaucoma
-
Drance SM, Sweeney VP, Morgan RW, et al. Studies of factors involved in the production of low tension glaucoma. Arch Ophthalmol. 1973;89: 457-465
-
(1973)
Arch Ophthalmol
, vol.89
, pp. 457-465
-
-
Drance, S.M.1
Sweeney, V.P.2
Morgan, R.W.3
-
13
-
-
0034094018
-
Ginkgo biloba extract: Mechanisms and clinical indications
-
Diamond BJ, Shiflett SC, Feiwel N, et al. Ginkgo biloba extract: Mechanisms and clinical indications. Arch Phys Med Rehabil. 2000;81: 668-678
-
(2000)
Arch Phys Med Rehabil
, vol.81
, pp. 668-678
-
-
Diamond, B.J.1
Shiflett, S.C.2
Feiwel, N.3
-
14
-
-
80055006038
-
Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: A randomized controlled trial
-
In press
-
Ihl R, Bachinskaya N, Korczyn AD, et al. Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: A randomized controlled trial. Int J Geriatr Psychiatry. 2010 In press
-
(2010)
Int J Geriatr Psychiatry
-
-
Ihl, R.1
Bachinskaya, N.2
Korczyn, A.D.3
-
15
-
-
0036255603
-
The efficacy of Ginkgo special extract EGb 761 in patients with tinnitus
-
Morgenstern C, Biermann E. The efficacy of Ginkgo special extract EGb 761 in patients with tinnitus. Int J Clin Pharmacol Ther. 2002;40: 188-197
-
(2002)
Int J Clin Pharmacol Ther
, Issue.40
, pp. 188-197
-
-
Morgenstern, C.1
Biermann, E.2
-
17
-
-
0027959503
-
Interaction between psychological and pharmacological treatment in cognitive impairment
-
Deberdt W. Interaction between psychological and pharmacological treatment in cognitive impairment. Life Sci. 1994; 55: 2057-2066
-
(1994)
Life Sci
, vol.55
, pp. 2057-2066
-
-
Deberdt, W.1
-
18
-
-
0033846696
-
Gingko biloba (Rokan) therapy in tinnitus patients and measurable interactions between tinnitus and vestibular disturbances
-
Schneider D, Schneider L, Shulman A, et al. Gingko biloba (Rokan) therapy in tinnitus patients and measurable interactions between tinnitus and vestibular disturbances. Int Tinnitus J. 2000;6: 56-62
-
(2000)
Int Tinnitus J.
, vol.6
, pp. 56-62
-
-
Schneider, D.1
Schneider, L.2
Shulman, A.3
-
19
-
-
1642404365
-
The Ginkgo biloba extract (EGb 761) provides a neuroprotective effect on retinal ganglion cells in a rat model of chronic glaucoma
-
Hirooka K, Tokuda M, Miyamoto O, et al. The Ginkgo biloba extract (EGb 761) provides a neuroprotective effect on retinal ganglion cells in a rat model of chronic glaucoma. Curr Eye Res. 2004;28: 153-157
-
(2004)
Curr Eye Res
, vol.28
, pp. 153-157
-
-
Hirooka, K.1
Tokuda, M.2
Miyamoto, O.3
-
21
-
-
0026357685
-
Therapeutic follow-up using automatic perimetry in chronic cerebroretinal ischemia in elderly patients prospective double-blind study with graduated dose ginkgo biloba treatment (egb 761)
-
Raabe A, Raabe M, Ihm P. Therapeutic follow-up using automatic perimetry in chronic cerebroretinal ischemia in elderly patients. Prospective double-blind study with graduated dose Ginkgo biloba treatment (EGb 761). Klin Monbl Augenheilkd. 1991;199: 432-438
-
(1991)
Klin Monbl Augenheilkd
, vol.199
, pp. 432-438
-
-
Raabe, A.1
Raabe, M.2
Ihm, P.3
-
22
-
-
0037314489
-
Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma
-
discussion 362-354
-
Quaranta L, Bettelli S, Uva MG, et al. Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma. Ophthalmology. 2003;110: 359-362; discussion 362-354
-
(2003)
Ophthalmology
, vol.110
, pp. 359-362
-
-
Quaranta, L.1
Bettelli, S.2
Uva, M.G.3
-
23
-
-
0027173798
-
The lens opacities classification system III the longitudinal study of cataract study group
-
Chylack LT Jr, Wolfe JK, Singer DM, et al. The lens opacities classification system III. The Longitudinal Study of Cataract Study Group. Arch Ophthalmol. 1993;111: 831-836
-
(1993)
Arch Ophthalmol
, vol.111
, pp. 831-836
-
-
Chylack Jr., L.T.1
Wolfe, J.K.2
Singer, D.M.3
-
25
-
-
0036211639
-
Long-Term followup of visual field progression after trabeculectomy in progressive normal-Tension glaucoma
-
Shigeeda T, Tomidokoro A, Araie M, et al. Long-Term followup of visual field progression after trabeculectomy in progressive normal-Tension glaucoma. Ophthalmology. 2002; 109: 766-770
-
(2002)
Ophthalmology
, vol.109
, pp. 766-770
-
-
Shigeeda, T.1
Tomidokoro, A.2
Araie, M.3
-
27
-
-
0034116017
-
Potential role for Ginkgo biloba extract in the treatment of glaucoma
-
Ritch R. Potential role for Ginkgo biloba extract in the treatment of glaucoma. Med Hypotheses. 2000;54: 221-235
-
(2000)
Med Hypotheses
, vol.54
, pp. 221-235
-
-
Ritch, R.1
-
28
-
-
0022958875
-
Proofs of involvement of PAF-Acether in various immune disorders using BN 52021 (ginkgolide B): A powerful PAF-Acether antagonist isolated from Ginkgo biloba L
-
Braquet P. Proofs of involvement of PAF-Acether in various immune disorders using BN 52021 (ginkgolide B): A powerful PAF-Acether antagonist isolated from Ginkgo biloba L. Adv Prostaglandin Thromboxane Leukot Res. 1986;16: 179-198
-
(1986)
Adv Prostaglandin Thromboxane Leukot Res
, vol.16
, pp. 179-198
-
-
Braquet, P.1
-
29
-
-
0023107863
-
Effect of a ginkgolide mixture (BN 52063) in antagonising skin and platelet responses to platelet activating factor in man
-
Chung KF, Dent G, McCusker M, et al. Effect of a ginkgolide mixture (BN 52063) in antagonising skin and platelet responses to platelet activating factor in man. Lancet. 1987;1: 248-251
-
(1987)
Lancet
, vol.1
, pp. 248-251
-
-
Chung, K.F.1
Dent, G.2
McCusker, M.3
-
30
-
-
0027081205
-
Enhancement of hippocampal excitatory synaptic transmission by plateletactivating factor
-
Clark GD, Happel LT, Zorumski CF, et al. Enhancement of hippocampal excitatory synaptic transmission by plateletactivating factor. Neuron. 1992;9: 1211-1216
-
(1992)
Neuron
, vol.9
, pp. 1211-1216
-
-
Clark, G.D.1
Happel, L.T.2
Zorumski, C.F.3
-
32
-
-
1842296303
-
Antagonistic effects of extract from leaves of Ginkgo biloba on glutamate neurotoxicity
-
Zhu L, Wu J, Liao H, et al. Antagonistic effects of extract from leaves of Ginkgo biloba on glutamate neurotoxicity. Zhongguo Yao Li Xue Bao. 1997;18: 344-347
-
(1997)
Zhongguo Yao Li Xue Bao
, vol.18
, pp. 344-347
-
-
Zhu, L.1
Wu, J.2
Liao, H.3
-
33
-
-
2642676874
-
Protective effects of Ginkgo biloba extract against lysophosphatidylcholine-induced vascular endothelial cell damage
-
Chen JX, Chen WZ, Huang HL, et al. Protective effects of Ginkgo biloba extract against lysophosphatidylcholine-induced vascular endothelial cell damage. Zhongguo Yao Li Xue Bao. 1998;19: 359-363
-
(1998)
Zhongguo Yao Li Xue Bao
, vol.19
, pp. 359-363
-
-
Chen, J.X.1
Chen, W.Z.2
Huang, H.L.3
-
35
-
-
0032417316
-
Inhibitory effect of the leaf extract of Ginkgo biloba L. on oxidative stress-induced platelet aggregation
-
Akiba S, Kawauchi T, Oka T, et al. Inhibitory effect of the leaf extract of Ginkgo biloba L. on oxidative stress-induced platelet aggregation. Biochem Mol Biol Int. 1998;46: 1243-1248
-
(1998)
Biochem Mol Biol Int
, vol.46
, pp. 1243-1248
-
-
Akiba, S.1
Kawauchi, T.2
Oka, T.3
-
36
-
-
0032989404
-
Additional information to the in vitro antioxidant activity of Ginkgo biloba L
-
Lugasi A, Horvahovich P, Dworschak E. Additional information to the in vitro antioxidant activity of Ginkgo biloba L. Phytother Res. 1999;13: 160-162
-
(1999)
Phytother Res
, vol.13
, pp. 160-162
-
-
Lugasi, A.1
Horvahovich, P.2
Dworschak, E.3
-
37
-
-
0029989628
-
The neuroprotective properties of the Ginkgo biloba leaf: A review of the possible relationship to platelet-Activating factor (PAF)
-
Smith PF, Maclennan K, Darlington CL. The neuroprotective properties of the Ginkgo biloba leaf: A review of the possible relationship to platelet-Activating factor (PAF). J Ethnopharmacol. 1996;50: 131-139
-
(1996)
J Ethnopharmacol
, vol.50
, pp. 131-139
-
-
Smith, P.F.1
Maclennan, K.2
Darlington, C.L.3
-
38
-
-
1242341490
-
Ginkgo biloba special extract EGb 761 in the treatment of peripheral arterial occlusive disease (PAOD) - A review based on randomized, controlled studies
-
Horsch S, Walther C. Ginkgo biloba special extract EGb 761 in the treatment of peripheral arterial occlusive disease (PAOD) - A review based on randomized, controlled studies. Int J Clin Pharmacol Ther. 2004;42: 63-72
-
(2004)
Int J Clin Pharmacol Ther
, vol.42
, pp. 63-72
-
-
Horsch, S.1
Walther, C.2
-
39
-
-
0028275692
-
Effects of natural antioxidant Ginkgo biloba extract (EGB 761) on myocardial ischemia-reperfusion injury
-
Haramaki N, Aggarwal S, Kawabata T, et al. Effects of natural antioxidant Ginkgo biloba extract (EGB 761) on myocardial ischemia-reperfusion injury. Free Radic Biol Med. 1994;16: 789-794
-
(1994)
Free Radic Biol Med
, vol.16
, pp. 789-794
-
-
Haramaki, N.1
Aggarwal, S.2
Kawabata, T.3
-
40
-
-
0030759072
-
A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia
-
North American EGb Study Group
-
Le Bars PL, Katz MM, Berman N, et al. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group. JAMA. 1997;278: 1327-1332
-
(1997)
JAMA
, vol.278
, pp. 1327-1332
-
-
Le Bars, P.L.1
Katz, M.M.2
Berman, N.3
-
41
-
-
0032972642
-
Effects of EGb761 and superoxide dismutase in an experimental model of retinopathy generated by intravitreal production of superoxide anion radical
-
Baudouin C, Pisella PJ, EttaicheM, et al. Effects of EGb761 and superoxide dismutase in an experimental model of retinopathy generated by intravitreal production of superoxide anion radical. Graefes Arch Clin Exp Ophthalmol. 1999;237: 58-66
-
(1999)
Graefes Arch Clin Exp Ophthalmol
, vol.237
, pp. 58-66
-
-
Baudouin, C.1
Pisella, P.J.2
Ettaiche, M.3
-
42
-
-
73849095077
-
Protective effects of Ginkgo biloba extract on morphology and function of retinal ganglion cells after optic nerve transection in guinea pigs
-
Xie ZG, Wu XW, Zhuang CR, et al. Protective effects of Ginkgo biloba extract on morphology and function of retinal ganglion cells after optic nerve transection in guinea pigs. Zhong Xi Yi Jie He Xue Bao. 2009;7: 940-946
-
(2009)
Zhong Xi Yi Jie He Xue Bao
, vol.7
, pp. 940-946
-
-
Xie, Z.G.1
Wu, X.W.2
Zhuang, C.R.3
-
43
-
-
77954635960
-
The effect of Ginkgo biloba on the rat retinal ganglion cell survival in the optic nerve crush model
-
Ma K, Xu L, Zhang H, et al. The effect of Ginkgo biloba on the rat retinal ganglion cell survival in the optic nerve crush model. Acta Ophthalmol. 2010;88: 553-557
-
(2010)
Acta Ophthalmol
, Issue.88
, pp. 553-557
-
-
Ma, K.1
Xu, L.2
Zhang, H.3
-
44
-
-
0033560362
-
Tutorial in biostatistics an introduction to hierarchical linear modelling
-
Sullivan LM, Dukes KA, Losina E. Tutorial in biostatistics. An introduction to hierarchical linear modelling. Stat Med. 1999;18: 855-888
-
(1999)
Stat Med
, vol.18
, pp. 855-888
-
-
Sullivan, L.M.1
Dukes, K.A.2
Losina, E.3
-
45
-
-
38349107673
-
A visual field index for calculation of glaucoma rate of progression
-
Bengtsson B, Heijl A. A visual field index for calculation of glaucoma rate of progression. Am J Ophthalmol. 2008;145: 343-353
-
(2008)
Am J Ophthalmol
, vol.145
, pp. 343-353
-
-
Bengtsson, B.1
Heijl, A.2
-
46
-
-
0030013973
-
Analysis of progressive change in automated visual fields in glaucoma
-
Smith SD, Katz J, Quigley HA. Analysis of progressive change in automated visual fields in glaucoma. Invest Ophthalmol Vis Sci. 1996;37: 1419-1428
-
(1996)
Invest Ophthalmol Vis Sci
, vol.37
, pp. 1419-1428
-
-
Smith, S.D.1
Katz, J.2
Quigley, H.A.3
-
47
-
-
0021051267
-
A comparative study of visual field defects seen in patients with low-Tension glaucoma and chronic simple glaucoma
-
Hitchings RA, Anderton SA. A comparative study of visual field defects seen in patients with low-Tension glaucoma and chronic simple glaucoma. Br J Ophthalmol. 1983;67: 818-821
-
(1983)
Br J Ophthalmol
, vol.67
, pp. 818-821
-
-
Hitchings, R.A.1
Anderton, S.A.2
-
48
-
-
0021262946
-
Comparison of visual field defects in the low-Tension glaucomas with those in the high-Tension glaucomas
-
Caprioli J, Spaeth GL. Comparison of visual field defects in the low-Tension glaucomas with those in the high-Tension glaucomas. Am J Ophthalmol. 1984;97: 730-737
-
(1984)
Am J Ophthalmol
, vol.97
, pp. 730-737
-
-
Caprioli, J.1
Spaeth, G.L.2
-
49
-
-
0027131608
-
Visual field defects in normaltension and high-Tension glaucoma
-
Araie M, Yamagami J, Suziki Y. Visual field defects in normaltension and high-Tension glaucoma. Ophthalmology. 1993;100: 1808-1814
-
(1993)
Ophthalmology
, vol.100
, pp. 1808-1814
-
-
Araie, M.1
Yamagami, J.2
Suziki, Y.3
-
50
-
-
0028905219
-
Pattern of visual field defects in normal-Tension and high-Tension glaucoma
-
Araie M. Pattern of visual field defects in normal-Tension and high-Tension glaucoma. Curr Opin Ophthalmol. 1995;6: 36-45
-
(1995)
Curr Opin Ophthalmol
, vol.6
, pp. 36-45
-
-
Araie, M.1
-
51
-
-
77958615049
-
Normal versus high tension glaucoma: A comparison of functional and structural defects
-
Thonginnetra O, Greenstein VC, Chu D, et al. Normal versus high tension glaucoma: A comparison of functional and structural defects. J Glaucoma. 2010;19: 151-157
-
(2010)
J Glaucoma
, Issue.19
, pp. 151-157
-
-
Thonginnetra, O.1
Greenstein, V.C.2
Chu, D.3
-
52
-
-
77949888590
-
Visual field progression differences between normal-Tension and exfoliative high-Tension glaucoma
-
Ahrlich KG, De Moraes CG, Teng CC, et al. Visual field progression differences between normal-Tension and exfoliative high-Tension glaucoma. Invest Ophthalmol Vis Sci. 2010;51: 1458-1463
-
(2010)
Invest Ophthalmol Vis Sci
, Issue.51
, pp. 1458-1463
-
-
Ahrlich, K.G.1
De Moraes, C.G.2
Teng, C.C.3
-
53
-
-
0033815489
-
Comparison of visual field progression in patients with normal pressure glaucoma between eyes with and without visual field loss that threatens fixation
-
Membrey WL, Poinoosawmy DP, Bunce C, et al. Comparison of visual field progression in patients with normal pressure glaucoma between eyes with and without visual field loss that threatens fixation. Br J Ophthalmol. 2000;84: 1154-1158
-
(2000)
Br J Ophthalmol
, vol.84
, pp. 1154-1158
-
-
Membrey, W.L.1
Poinoosawmy, D.P.2
Bunce, C.3
-
54
-
-
78649839026
-
Retinal nerve fiber layer imaging with spectral-domain optical coherence tomography: Pattern of RNFL defects in glaucoma
-
Leung CK, Choi N, Weinreb RN, et al. Retinal nerve fiber layer imaging with spectral-domain optical coherence tomography: Pattern of RNFL defects in glaucoma. Ophthalmology. 2010;117: 2337-2344
-
(2010)
Ophthalmology
, Issue.117
, pp. 2337-2344
-
-
Leung, C.K.1
Choi, N.2
Weinreb, R.N.3
-
55
-
-
77952480852
-
Patterns of progression of localized retinal nerve fibre layer defect on red-free fundus photographs in normal-Tension glaucoma
-
Suh MH, Kim DM, Kim YK, et al. Patterns of progression of localized retinal nerve fibre layer defect on red-free fundus photographs in normal-Tension glaucoma. Eye (Lond). 2010; 24: 857-863
-
(2010)
Eye (Lond).
, Issue.24
, pp. 857-863
-
-
Suh, M.H.1
Kim, D.M.2
Kim, Y.K.3
-
56
-
-
10744228958
-
Achieving low target pressures with today's glaucoma medications
-
Cantor L. Achieving low target pressures with today's glaucoma medications. Surv Ophthalmol. 2003;48(suppl 1): S8-S16
-
(2003)
Surv Ophthalmol
, vol.48
, Issue.SUPPL.1
-
-
Cantor, L.1
|